Faculty of Dentistry, Thammasat University, Pathum Thani, Thailand.
Drug Delivery System Excellence Center, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
BMC Complement Med Ther. 2024 Jul 20;24(1):276. doi: 10.1186/s12906-024-04450-0.
BACKGROUND: Plant-derived compounds have chemopreventive properties to be used as alternative medicine. Pericarp of Mangosteen (Garcinia mangostana Linn.), a tropical fruit in Southeast Asia contains a phytochemical α-mangostin (α-MG) that demonstrates potent anticancer effects against various types of cancer. α-MG has been reported to be the most effective agent in human cancer cell lines. The objectives of this study were to develop oral gel formulations containing α-MG and determine their (1) anticancer activity, (2) anti-HPV-16 and antimicrobial activities, (3) nitric oxide (NO) inhibitory activity, and (4) wound healing effect. METHODS: Formulations of oral gel containing α-MG were developed. Anticancer activity on SCC-25 was assessed. Apoptotic induction was determined using flow cytometry technique. Antiviral activity against HPV-16 pseudovirus and antimicrobial activity against S. mutans, P. gingivalis and C. albicans were investigated. NO inhibition was carried out. Fibroblast cell migration was determined by in vitro scratch assay. RESULTS: The formulation of 1% α-MG in orabase gel demonstrated anticancer activity by promoting apoptosis in SCC-25. The induction of apoptotic activity was dose dependent with pronounced effect in late apoptosis. The formulation appeared to reduce cell viability of oral keratinocytes (OKC). At CC it showed an inhibition against HPV-16 pseudovirus infection. The formulation had no antimicrobial activity against S. mutans, P. gingivalis and C. albicans. No significant NO inhibitory activity and wound healing effects were found. CONCLUSIONS: 1% α-MG in orabase gel exhibited anticancer activity by inducing apoptosis although low level of cytotoxicity observed in OKC was present. The appropriate carrier for novel nano-particles targeting cancer cells should be further investigated.
背景:植物化合物具有化学预防特性,可作为替代药物使用。东南亚热带水果藤黄果皮含有一种植物化学物质 α-倒捻子素(α-MG),对多种类型的癌症具有强大的抗癌作用。α-MG 已被报道为人类癌细胞系中最有效的药物。本研究的目的是开发含有 α-MG 的口服凝胶制剂,并确定其(1)抗癌活性、(2)抗 HPV-16 和抗菌活性、(3)一氧化氮(NO)抑制活性和(4)伤口愈合作用。 方法:开发含有 α-MG 的口服凝胶制剂。评估对 SCC-25 的抗癌活性。使用流式细胞术技术确定细胞凋亡诱导。研究针对 HPV-16 假病毒的抗病毒活性和针对 S. mutans、P. gingivalis 和 C. albicans 的抗菌活性。进行了 NO 抑制。通过体外划痕试验测定成纤维细胞迁移。 结果:1%α-MG 在 orabase 凝胶中的制剂通过促进 SCC-25 中的细胞凋亡表现出抗癌活性。凋亡活性的诱导呈剂量依赖性,晚期凋亡的效果明显。该制剂似乎降低了口腔角质形成细胞(OKC)的细胞活力。在 CC 时,它显示出对 HPV-16 假病毒感染的抑制作用。该制剂对 S. mutans、P. gingivalis 和 C. albicans 没有抗菌活性。未发现明显的 NO 抑制活性和伤口愈合作用。 结论:1%α-MG 在 orabase 凝胶中的制剂通过诱导细胞凋亡表现出抗癌活性,尽管 OKC 中存在低水平的细胞毒性。应该进一步研究针对癌细胞的新型纳米颗粒的适当载体。
BMC Complement Med Ther. 2024-7-20
BMC Oral Health. 2021-10-10
Asian Pac J Cancer Prev. 2020-9-1
Eur J Pharmacol. 2019-9-19
Heliyon. 2024-9-26
J Int Soc Prev Community Dent. 2022-4-8
BMC Oral Health. 2021-10-10
Eur J Pharmacol. 2019-9-19
Arch Oral Biol. 2018-3-6
Oral Surg Oral Med Oral Pathol Oral Radiol. 2018-6
Evid Based Complement Alternat Med. 2016